Edwards Lifesciences Corp financial data

Symbol
EW on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
One Edwards Way, Irvine, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
CVG CONTROLLED INC (to 1/21/2000)
Latest financial report
10-Q - Q2 2024 - Jul 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 353 % +9.04%
Quick Ratio 87.8 % +4.06%
Debt-to-equity 37.4 % -9.22%
Return On Equity 20.9 %
Return On Assets 15.3 %
Operating Margin 26.3 % -5.09%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 602M shares -0.91%
Common Stock, Shares, Outstanding 602M shares -0.92%
Entity Public Float 56.8B USD -2.74%
Common Stock, Value, Issued 654M USD +0.68%
Weighted Average Number of Shares Outstanding, Basic 602M shares -0.79%
Weighted Average Number of Shares Outstanding, Diluted 604M shares -0.98%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.23B USD +15%
Research and Development Expense 1.12B USD +15.9%
Operating Income (Loss) 1.64B USD +9.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.72B USD +11.7%
Income Tax Expense (Benefit) 198M USD -2.65%
Net Income (Loss) Attributable to Parent 1.47B USD +19.3%
Earnings Per Share, Basic 2.43 USD/shares +6.58%
Earnings Per Share, Diluted 2.43 USD/shares +7.52%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.64B USD +57.7%
Accounts Receivable, after Allowance for Credit Loss, Current 778M USD +3.17%
Inventory, Net 1.02B USD +4.54%
Other Assets, Current 252M USD +16%
Assets, Current 4.52B USD +23.8%
Deferred Income Tax Assets, Net 833M USD +36.3%
Property, Plant and Equipment, Net 1.64B USD -1.33%
Operating Lease, Right-of-Use Asset 92.8M USD +9.31%
Intangible Assets, Net (Excluding Goodwill) 417M USD -3.32%
Goodwill 1.15B USD -11.4%
Other Assets, Noncurrent 790M USD +91.7%
Assets 10.1B USD +12.2%
Accounts Payable, Current 186M USD -3.68%
Employee-related Liabilities, Current 289M USD -7.68%
Liabilities, Current 1.22B USD +5.17%
Operating Lease, Liability, Noncurrent 74.2M USD +16.9%
Other Liabilities, Noncurrent 257M USD +5.93%
Liabilities 2.59B USD +1.46%
Accumulated Other Comprehensive Income (Loss), Net of Tax -220M USD +13.8%
Retained Earnings (Accumulated Deficit) 9.71B USD +17.9%
Stockholders' Equity Attributable to Parent 7.44B USD +16.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 7.5B USD +16.4%
Liabilities and Equity 10.1B USD +12.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -53.5M USD -117%
Net Cash Provided by (Used in) Financing Activities 61.7M USD
Net Cash Provided by (Used in) Investing Activities 63.1M USD +12520%
Common Stock, Shares Authorized 1.05B shares 0%
Common Stock, Shares, Issued 654M shares +0.68%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 81M USD -22%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.66B USD +58.3%
Deferred Tax Assets, Valuation Allowance 90.2M USD -8.98%
Deferred Tax Assets, Gross 958M USD +37.6%
Operating Lease, Liability 97.9M USD +3.05%
Payments to Acquire Property, Plant, and Equipment 65.3M USD +6.18%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.51B USD +11%
Lessee, Operating Lease, Liability, to be Paid 106M USD +3.02%
Property, Plant and Equipment, Gross 2.61B USD +9.38%
Operating Lease, Liability, Current 21.5M USD -11.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 19.6M USD +5.95%
Lessee, Operating Lease, Liability, to be Paid, Year One 26.8M USD -0.74%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.9M USD +2.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.3M USD +30.4%
Deferred Tax Assets, Operating Loss Carryforwards 75.9M USD +5.86%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 619M USD +19.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.9M USD +22.9%
Operating Lease, Payments 8.2M USD +15.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 38.5M USD +9.38%
Share-based Payment Arrangement, Expense 149M USD +13.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%